Trials / Unknown
UnknownNCT03868969
Clinical Efficacy of Fosfomycin Trometamol Per os in the Treatment of Documented Male Urinary Tract Infections With ESBL-producing Enterobacteriaceae With ESBL Producing Enterobacteriaceae and Resistance Associated With Fluoroquinolones and Cotrimoxazole (FOSF'HOM)
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to evaluate the clinical and microbiological efficacy of fosfomycin trometamol (FT) per os in the treatment of documented male urinary tract infections with ESBL-producing enterobacteriaceae
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fosfomycin Oral Suspension | Man with urinary tract infections with BLSE enterobacteriaceae will be treated by fosfomycin 1 packet by day for 21 days |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2021-04-01
- Completion
- 2021-09-01
- First posted
- 2019-03-11
- Last updated
- 2019-03-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03868969. Inclusion in this directory is not an endorsement.